- Report
- April 2024
- 80 Pages
From €2489EUR$2,595USD£2,139GBP
- Report
- April 2024
- 80 Pages
From €2489EUR$2,595USD£2,139GBP
- Report
- April 2024
- 80 Pages
From €2489EUR$2,595USD£2,139GBP
- Report
- April 2024
- 80 Pages
From €2489EUR$2,595USD£2,139GBP
- Report
- April 2024
- 80 Pages
From €2489EUR$2,595USD£2,139GBP
- Report
- April 2024
- 80 Pages
From €2489EUR$2,595USD£2,139GBP
- Report
- April 2024
- 80 Pages
From €2489EUR$2,595USD£2,139GBP
- Report
- April 2024
- 80 Pages
From €2489EUR$2,595USD£2,139GBP
- Report
- April 2024
- 80 Pages
From €2489EUR$2,595USD£2,139GBP
- Report
- April 2024
- 80 Pages
From €2489EUR$2,595USD£2,139GBP
- Report
- April 2024
- 80 Pages
From €2489EUR$2,595USD£2,139GBP
- Report
- April 2024
- 80 Pages
From €2489EUR$2,595USD£2,139GBP
- Report
- June 2021
Global
From €7195EUR$7,500USD£6,181GBP
From €7195EUR$7,500USD£6,181GBP
- Report
- December 2023
- 85 Pages
Global
From €3500EUR$3,908USD£3,112GBP
- Report
- June 2023
- 73 Pages
Global
From €3500EUR$3,908USD£3,112GBP
An intracranial stent is a medical device used to treat conditions such as intracranial stenosis, aneurysms, and arteriovenous malformations. It is a small, flexible tube made of metal or plastic that is inserted into the brain to keep the artery open and allow for improved blood flow. Intracranial stents are typically used in combination with other treatments such as angioplasty, embolization, and endovascular coiling.
The intracranial stent market is a rapidly growing segment of the overall stent market. It is driven by the increasing prevalence of neurological disorders, technological advancements, and the growing demand for minimally invasive treatments. The market is expected to witness a steady growth in the coming years due to the increasing demand for minimally invasive treatments and the growing awareness of the benefits of intracranial stents.
Some of the major companies in the intracranial stent market include Medtronic, Abbott, Johnson & Johnson, Boston Scientific, and Stryker. Show Less Read more